{"transactions":[{"id":3994,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:06:51.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":102,"price":113.38,"value":11564.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on September 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16304,"source":{"system":"sec-edgar","filing":"0001193125-26-382463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1678419/000119312526382463/ownership.xml","form_type":"4"}},{"id":3993,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:06:51.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16406,"source":{"system":"sec-edgar","filing":"0001193125-26-382463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1678419/000119312526382463/ownership.xml","form_type":"4"}},{"id":3992,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:06:51.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":138,"price":113.38,"value":15646.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16268,"source":{"system":"sec-edgar","filing":"0001193125-26-382463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678419/000119312526382463/ownership.xml","form_type":"4"}},{"id":699244,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"exercise","planned":true,"acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Fully exercisable."}],"balance_after":95833,"derivative":{"exercise_price":23.06,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699243,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":1001,"price":120.6749,"value":120795.5749,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $120.49 to $120.84 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16130,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699242,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":8103,"price":119.9481,"value":971939.4543,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.42 to $120.41 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":17131,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699241,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":4783,"price":118.7346,"value":567907.5918,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.42 to $119.21 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":25234,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699240,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":8267,"price":117.9329,"value":974951.2843,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.41 to $118.39 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":30017,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699239,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":7089,"price":116.9561,"value":829101.7929,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.35 to $117.3 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":38284,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699238,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":14222,"price":115.8669,"value":1647859.0518,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.35 to $116.27 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":45373,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699237,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":15477,"price":114.9601,"value":1779237.4677,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.305 to $115.30 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":59595,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699236,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":4700,"price":113.1789,"value":531940.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.96 to $113.89 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":75072,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699235,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":600,"price":110.95,"value":66570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":79772,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699234,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":2202,"price":110.0283,"value":242282.3166,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $109.71 to $110.42 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":80372,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699233,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":400,"price":108.46,"value":43384.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":82574,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699232,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":8956,"price":106.9553,"value":957891.6668,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $106.75 to $107.195 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":82974,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699231,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":4200,"price":105.5352,"value":443247.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $105.305 to $106.2 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":91930,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":699230,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:30:22.000Z","date":"2026-07-30","kind":"exercise","planned":true,"acquired":true,"shares":80000,"price":23.06,"value":1844800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":96130,"source":{"system":"sec-edgar","filing":"0001193125-26-330668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526330668/ownership.xml","form_type":"4"}},{"id":707371,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-07-17T22:31:34.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":24167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully exercisable."}],"balance_after":175833,"derivative":{"exercise_price":23.06,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":24167},"source":{"system":"sec-edgar","filing":"0001193125-26-308058","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526308058/ownership.xml","form_type":"4"}},{"id":707370,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-07-17T22:31:34.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":15833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully exercisable."}],"balance_after":4167,"derivative":{"exercise_price":19.26,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":15833},"source":{"system":"sec-edgar","filing":"0001193125-26-308058","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526308058/ownership.xml","form_type":"4"}},{"id":707369,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-17T22:31:34.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":101,"price":89.4282,"value":9032.2482,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $89.25 to $89.43 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16130,"source":{"system":"sec-edgar","filing":"0001193125-26-308058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526308058/ownership.xml","form_type":"4"}},{"id":707368,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-17T22:31:34.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":3520,"price":88.3016,"value":310821.632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $88.24 to $89.07 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16231,"source":{"system":"sec-edgar","filing":"0001193125-26-308058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526308058/ownership.xml","form_type":"4"}},{"id":707367,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-17T22:31:34.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":28460,"price":87.8863,"value":2501244.098,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $87.23 to $88.21 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":19751,"source":{"system":"sec-edgar","filing":"0001193125-26-308058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526308058/ownership.xml","form_type":"4"}},{"id":707366,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-17T22:31:34.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":7919,"price":86.776,"value":687179.144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $86.20 to $87.19 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":48211,"source":{"system":"sec-edgar","filing":"0001193125-26-308058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526308058/ownership.xml","form_type":"4"}},{"id":707365,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-17T22:31:34.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":24167,"price":23.06,"value":557291.02,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":56130,"source":{"system":"sec-edgar","filing":"0001193125-26-308058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526308058/ownership.xml","form_type":"4"}},{"id":707364,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-17T22:31:34.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":15833,"price":19.26,"value":304943.58,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":31963,"source":{"system":"sec-edgar","filing":"0001193125-26-308058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526308058/ownership.xml","form_type":"4"}},{"id":734983,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-06-17T20:30:04.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully exercisable."}],"balance_after":20000,"derivative":{"exercise_price":19.26,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001193125-26-274224","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526274224/ownership.xml","form_type":"4"}},{"id":734982,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T20:30:04.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":2,"price":82.45,"value":164.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16130,"source":{"system":"sec-edgar","filing":"0001193125-26-274224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526274224/ownership.xml","form_type":"4"}},{"id":734981,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T20:30:04.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":19483,"price":81.8092,"value":1593888.6436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $81.40 to $82.18 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16132,"source":{"system":"sec-edgar","filing":"0001193125-26-274224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526274224/ownership.xml","form_type":"4"}},{"id":734980,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T20:30:04.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":11081,"price":80.9424,"value":896922.7344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.40 to $81.39 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":35615,"source":{"system":"sec-edgar","filing":"0001193125-26-274224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526274224/ownership.xml","form_type":"4"}},{"id":734979,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T20:30:04.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":9434,"price":80.0216,"value":754923.7744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.40 to $80.39 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":46696,"source":{"system":"sec-edgar","filing":"0001193125-26-274224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526274224/ownership.xml","form_type":"4"}},{"id":734978,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T20:30:04.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":19.26,"value":770400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":56130,"source":{"system":"sec-edgar","filing":"0001193125-26-274224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526274224/ownership.xml","form_type":"4"}},{"id":752875,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-06-03T23:20:22.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Fully exercisable."}],"balance_after":60000,"derivative":{"exercise_price":19.26,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001193125-26-256011","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256011/ownership.xml","form_type":"4"}},{"id":752874,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:22.000Z","date":"2026-06-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":395,"price":70.44,"value":27823.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The closing price on June 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16130,"source":{"system":"sec-edgar","filing":"0001193125-26-256011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256011/ownership.xml","form_type":"4"}},{"id":752873,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:22.000Z","date":"2026-06-01","kind":"grant","planned":true,"acquired":true,"shares":634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16525,"source":{"system":"sec-edgar","filing":"0001193125-26-256011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256011/ownership.xml","form_type":"4"}},{"id":752872,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:22.000Z","date":"2026-06-01","kind":"grant","planned":true,"acquired":true,"shares":634,"price":70.44,"value":44658.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":15891,"source":{"system":"sec-edgar","filing":"0001193125-26-256011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256011/ownership.xml","form_type":"4"}},{"id":752871,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:22.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":70.0001,"value":2800004.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.00 to $70.01 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":15257,"source":{"system":"sec-edgar","filing":"0001193125-26-256011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256011/ownership.xml","form_type":"4"}},{"id":752870,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:22.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":19.26,"value":770400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":55257,"source":{"system":"sec-edgar","filing":"0001193125-26-256011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256011/ownership.xml","form_type":"4"}},{"id":863052,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T01:20:13.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":96,"price":35.97,"value":3453.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on March 2, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":15257,"source":{"system":"sec-edgar","filing":"0001193125-26-092155","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092155/ownership.xml","form_type":"4"}},{"id":863051,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T01:20:13.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":15353,"source":{"system":"sec-edgar","filing":"0001193125-26-092155","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092155/ownership.xml","form_type":"4"}},{"id":863050,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T01:20:13.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":397,"price":35.97,"value":14280.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14956,"source":{"system":"sec-edgar","filing":"0001193125-26-092155","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092155/ownership.xml","form_type":"4"}},{"id":870158,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T23:16:26.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercise ratably in equal installments on each monthly anniversary of February 27, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":35.7,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001193125-26-089018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526089018/ownership.xml","form_type":"4"}},{"id":982394,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:25:48.000Z","date":"2025-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":118,"price":79.78,"value":9414.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on December 1, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14559,"source":{"system":"sec-edgar","filing":"0001193125-25-307218","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307218/ownership.xml","form_type":"4"}},{"id":982393,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:25:48.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14677,"source":{"system":"sec-edgar","filing":"0001193125-25-307218","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307218/ownership.xml","form_type":"4"}},{"id":982392,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:25:48.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":178,"price":79.78,"value":14200.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14499,"source":{"system":"sec-edgar","filing":"0001193125-25-307218","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307218/ownership.xml","form_type":"4"}},{"id":1048519,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:53:18.000Z","date":"2025-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":144,"price":71.38,"value":10278.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on September 2, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, and 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issues on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14321,"source":{"system":"sec-edgar","filing":"0001193125-25-196312","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196312/ownership.xml","form_type":"4"}},{"id":1048518,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:53:18.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, and 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issues on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14465,"source":{"system":"sec-edgar","filing":"0001193125-25-196312","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196312/ownership.xml","form_type":"4"}},{"id":1048517,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:53:18.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":200,"price":71.38,"value":14276.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, and 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issues on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14265,"source":{"system":"sec-edgar","filing":"0001193125-25-196312","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196312/ownership.xml","form_type":"4"}},{"id":1123568,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:32:17.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":519,"price":71.68,"value":37201.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on June 2, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14065,"source":{"system":"sec-edgar","filing":"0000950170-25-081930","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081930/ownership.xml","form_type":"4"}},{"id":1123567,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:32:17.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14584,"source":{"system":"sec-edgar","filing":"0000950170-25-081930","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081930/ownership.xml","form_type":"4"}},{"id":1123566,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:32:17.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":775,"price":71.68,"value":55552.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 2, 2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13809,"source":{"system":"sec-edgar","filing":"0000950170-25-081930","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081930/ownership.xml","form_type":"4"}},{"id":1231338,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T00:34:41.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Exercise ratably in equal installments on each monthly anniversary of February 28, 2025 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":60.58,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000950170-25-032725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032725/ownership.xml","form_type":"4"}},{"id":1231337,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:34:41.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13034,"source":{"system":"sec-edgar","filing":"0000950170-25-032725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032725/ownership.xml","form_type":"4"}},{"id":1231336,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:34:41.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":232,"price":59.07,"value":13704.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12802,"source":{"system":"sec-edgar","filing":"0000950170-25-032725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032725/ownership.xml","form_type":"4"}},{"id":1231335,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:34:41.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":228,"price":60.58,"value":13812.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on February 28, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12570,"source":{"system":"sec-edgar","filing":"0000950170-25-032725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032725/ownership.xml","form_type":"4"}},{"id":1343603,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T00:34:34.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12798,"source":{"system":"sec-edgar","filing":"0000950170-24-133432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024133432/ownership.xml","form_type":"4"}},{"id":1343602,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T00:34:34.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":231,"price":59.21,"value":13677.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12567,"source":{"system":"sec-edgar","filing":"0000950170-24-133432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024133432/ownership.xml","form_type":"4"}},{"id":1343601,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T00:34:34.000Z","date":"2024-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":182,"price":57.68,"value":10497.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on November 29, 2024 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12336,"source":{"system":"sec-edgar","filing":"0000950170-24-133432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024133432/ownership.xml","form_type":"4"}},{"id":1414495,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-06T00:24:14.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12518,"source":{"system":"sec-edgar","filing":"0000950170-24-104202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024104202/ownership.xml","form_type":"4"}},{"id":1414494,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-06T00:24:14.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":400,"price":34.26,"value":13704.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12118,"source":{"system":"sec-edgar","filing":"0000950170-24-104202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024104202/ownership.xml","form_type":"4"}},{"id":1414493,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-06T00:24:14.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":143,"price":35.3,"value":5047.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on August 30, 2024 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":11718,"source":{"system":"sec-edgar","filing":"0000950170-24-104202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024104202/ownership.xml","form_type":"4"}},{"id":1490710,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-06T01:10:05.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":1448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":11861,"source":{"system":"sec-edgar","filing":"0000950170-24-069598","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024069598/ownership.xml","form_type":"4"}},{"id":1490709,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-06T01:10:05.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":1448,"price":31.3,"value":45322.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10413,"source":{"system":"sec-edgar","filing":"0000950170-24-069598","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024069598/ownership.xml","form_type":"4"}},{"id":1490708,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-06T01:10:05.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":571,"price":30.17,"value":17227.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on May 31, 2024 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8965,"source":{"system":"sec-edgar","filing":"0000950170-24-069598","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024069598/ownership.xml","form_type":"4"}},{"id":1598845,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-06T02:03:06.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9536,"source":{"system":"sec-edgar","filing":"0000950170-24-026760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024026760/ownership.xml","form_type":"4"}},{"id":1598844,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-06T02:03:06.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":554,"price":24.06,"value":13329.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8982,"source":{"system":"sec-edgar","filing":"0000950170-24-026760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024026760/ownership.xml","form_type":"4"}},{"id":1598843,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-06T02:03:06.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":517,"price":24.06,"value":12439.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8428,"source":{"system":"sec-edgar","filing":"0000950170-24-026760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024026760/ownership.xml","form_type":"4"}},{"id":1647146,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-02-14T00:40:45.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period."}],"balance_after":200000,"derivative":{"exercise_price":23.01,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-24-014855","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024014855/ownership.xml","form_type":"4"}},{"id":1722559,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-05T23:53:09.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8945,"source":{"system":"sec-edgar","filing":"0000950170-23-068364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017023068364/ownership.xml","form_type":"4"}},{"id":1722558,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-05T23:53:09.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":508,"price":25.97,"value":13192.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on December 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Form 4 previously filed inadvertently overstated the number of shares held by 275. The number in Column 5 reflects the corrected amount."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8437,"source":{"system":"sec-edgar","filing":"0000950170-23-068364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017023068364/ownership.xml","form_type":"4"}},{"id":1787824,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-06T22:41:03.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8204,"source":{"system":"sec-edgar","filing":"0000950170-23-046818","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017023046818/ownership.xml","form_type":"4"}},{"id":1787823,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-06T22:41:03.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":398,"price":33.1,"value":13173.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7806,"source":{"system":"sec-edgar","filing":"0000950170-23-046818","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017023046818/ownership.xml","form_type":"4"}},{"id":1867944,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-05T23:03:36.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":1651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7408,"source":{"system":"sec-edgar","filing":"0000899243-23-014514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924323014514/doc4.xml","form_type":"4"}},{"id":1867943,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-05T23:03:36.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":1651,"price":22.97,"value":37923.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on June 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":5757,"source":{"system":"sec-edgar","filing":"0000899243-23-014514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924323014514/doc4.xml","form_type":"4"}},{"id":1975699,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T23:54:23.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":1260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4106,"source":{"system":"sec-edgar","filing":"0000899243-23-007054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924323007054/doc4.xml","form_type":"4"}},{"id":1975698,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T23:54:23.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":1260,"price":19.86,"value":25023.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":2846,"source":{"system":"sec-edgar","filing":"0000899243-23-007054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924323007054/doc4.xml","form_type":"4"}},{"id":2014089,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-02-16T00:59:14.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of February 13, 2023 over a four-year period."}],"balance_after":200000,"derivative":{"exercise_price":23.06,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-23-005174","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924323005174/doc4.xml","form_type":"4"}},{"id":2166375,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-07T00:50:14.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements under the Purchase Plan."}],"balance_after":1586,"source":{"system":"sec-edgar","filing":"0000899243-22-030514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322030514/doc4.xml","form_type":"4"}},{"id":2166374,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-07T00:50:14.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":793,"price":25.98,"value":20602.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."}],"balance_after":793,"source":{"system":"sec-edgar","filing":"0000899243-22-030514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322030514/doc4.xml","form_type":"4"}},{"id":2402463,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-11T23:56:17.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 2, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on February 2, 2026."}],"balance_after":100000,"derivative":{"exercise_price":19.26,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-005954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322005954/doc4.xml","form_type":"4"}},{"id":2815698,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-03T22:58:58.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option vest and become exercisable with respect to 25% of the shares on the first anniversary of the date of grant with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on the fourth anniversary of the date of grant, subject to the Reporting Person's continued service."}],"balance_after":400000,"derivative":{"exercise_price":25.46,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000899243-21-009474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924321009474/doc4.xml","form_type":"4"}},{"id":3179019,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-09T18:42:58.000Z","date":"2020-04-08","kind":"grant","acquired":true,"shares":21792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on April 8, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on April 8, 2021."}],"balance_after":21792,"derivative":{"underlying":"Common Stock","underlying_shares":21792},"source":{"system":"sec-edgar","filing":"0001628280-20-004836","document":"wf-form4_158645775951286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678419/000162828020004836/wf-form4_158645775951286.xml","form_type":"4"}},{"id":3292010,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-04T19:26:07.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":540000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on February 3, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"derivative":{"exercise_price":1.36,"expiration_date":"2030-02-02","underlying":"Common Stock","underlying_shares":540000},"source":{"system":"sec-edgar","filing":"0001628280-20-000993","document":"wf-form4_158084435057170.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678419/000162828020000993/wf-form4_158084435057170.xml","form_type":"4"}},{"id":3723414,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP  and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T02:14:12.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on December 19, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":300000,"derivative":{"exercise_price":3.42,"expiration_date":"2028-12-18","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-18-063787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678419/000120919118063787/doc4.xml","form_type":"4"}},{"id":3733039,"issuer":{"id":7882,"kind":"organization","name":"IRIDEX CORP","symbol":"IRIX"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and VP Corp Development"}}],"security":"Common Stock","published_at":"2018-12-14T01:57:26.000Z","date":"2018-12-11","kind":"tax_withholding","acquired":false,"shares":180,"price":4.1,"value":738.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares have been withheld in an exempt disposition to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":81787,"source":{"system":"sec-edgar","filing":"0001704739-18-000057","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006045/000170473918000057/edgar.xml","form_type":"4"}},{"id":3733038,"issuer":{"id":7882,"kind":"organization","name":"IRIDEX CORP","symbol":"IRIX"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and VP Corp Development"}}],"security":"Common Stock","published_at":"2018-12-14T01:57:26.000Z","date":"2018-11-24","kind":"tax_withholding","acquired":false,"shares":5833,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares withheld through November 24, 2018 in exempt dispositions to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent sales by the Reporting Person.  Determination of the number of shares withheld was based upon the closing prices of the Issuer's Common Stock on the dates withheld."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects shares withheld through November 24, 2018 in exempt dispositions to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent sales by the Reporting Person.  Determination of the number of shares withheld was based upon the closing prices of the Issuer's Common Stock on the dates withheld."}],"balance_after":81967,"source":{"system":"sec-edgar","filing":"0001704739-18-000057","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006045/000170473918000057/edgar.xml","form_type":"4"}},{"id":3858176,"issuer":{"id":7882,"kind":"organization","name":"IRIDEX CORP","symbol":"IRIX"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and VP Corp Development"}}],"security":"Common Stock","published_at":"2018-07-31T20:17:34.000Z","date":"2018-07-28","kind":"grant","acquired":true,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"). The RSUs vest as to one-third of the shares on July 27, 2019 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":87800,"source":{"system":"sec-edgar","filing":"0001704739-18-000039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006045/000170473918000039/edgar.xml","form_type":"4"}},{"id":4251357,"issuer":{"id":7882,"kind":"organization","name":"IRIDEX CORP","symbol":"IRIX"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and VP Corp Development"}}],"security":"Stock Option Right to Buy","published_at":"2017-07-27T01:55:36.000Z","date":"2017-07-24","kind":"exercise","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the option vest over a period of 48 months with 1/4th of the total number of shares vesting on the first anniversary of the grant date and 1/48th of the total number of shares vesting each month thereafter."}],"balance_after":63000,"derivative":{"exercise_price":9.54,"expiration_date":"2024-07-24","underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001704739-17-000015","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006045/000170473917000015/edgar.xml","form_type":"4"}},{"id":4251356,"issuer":{"id":7882,"kind":"organization","name":"IRIDEX CORP","symbol":"IRIX"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and VP Corp Development"}}],"security":"Common Stock","published_at":"2017-07-27T01:55:36.000Z","date":"2017-07-24","kind":"grant","acquired":true,"shares":6000,"price":9.54,"value":57240.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Restricted stock units vest over a period of 48 months with 1/4th of the total number of units vesting on the first anniversary of the grant date and 1/48th of the total number of units vesting each month thereafter. Restriced stock units convert into common stock on a one-for-one basis."}],"balance_after":71000,"source":{"system":"sec-edgar","filing":"0001704739-17-000015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006045/000170473917000015/edgar.xml","form_type":"4"}}]}